to the unique combination of IG + Hy. HyQvia can meet you where you are*

*HyQvia can be administered across multiple sites of care, including hospitals, infusion centers, offices, or at home with the support of a healthcare professional. Appropriate training is required prior to self-infusion.

Get to know HyQvia as a maintenance therapy for adult patients with CIDP

CIDP=chronic inflammatory demyelinating polyneuropathy; IG=immune globulin; Hy=hyaluronidase.

Hospital and home icon depicting HYQVIA offers flexible infusion options across multiple sites of care.

Flexible site of care options

HyQvia gives you the choice to receive infusions at a center or at home, after appropriate training.

Calendar icon depicting HYQVIA allows infusions every 3-4 weeks.

2-hour average monthly infusions

Up to 4-week§ dosing intervals means you may get time back between infusions.

Infusion time median (range): 116.5 (65, 259) minutes.

§Every 2, 3, or 4 weeks.

Proven relapse prevention

HyQvia is a CIDP maintenance therapy that offers proven relapse prevention in adult patients.

HyQvia may help you as a maintenance therapy for adult patients with CIDP.

Established safety profile

Please see the Important Safety Information and serious WARNINGS regarding blood clots below.

In a clinical study, overall the most common side effects of HyQvia are headache, fatigue, nausea, fever, itching, redness, abdominal pain, back pain, pain in extremity.

Local reactions, meaning they occur around the infusion site, are common. The following local reactions may occur at the site of infusion and generally go away in a few hours: mild or moderate pain, redness, swelling, itching. Local reactions are less likely after the first few infusions. More than two thirds of patients did not develop local adverse reactions with HyQvia. For those who did, all were mild or moderate.

These are not all the possible side effects for HyQvia. Talk to your healthcare professional about any side effects that bother you or that do not go away.

||Local ARs were reported in 27% of subjects; 73% did not report local ARs.

Find safety information here.

This is where you’ll find important safety info, including the warning about blood clots, to consider when starting and monitoring your treatment with HyQvia and to discuss with your doctor.

Person icon.

We want to hear from you!

Currently managing your CIDP with HyQvia? How is it going? Tell us your story and inspire others.

E-mail icon.

We only send the kind of emails you want to read.

Sign up to learn more and receive HyQvia information sent straight to you. We’re happy to stay connected.

AR=adverse reaction.